By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tobira Therapeutics Inc. 

214 Carnegie Center
Suite 306
Princeton  New Jersey  08540  U.S.A.
Phone: 609-897-1102 Fax: n/a


SEARCH JOBS








Company News
Tobira Therapeutics Inc. Highlights Presentations At The International Liver Congress 2015 4/8/2015 7:40:56 AM
Tobira Therapeutics Inc. Highlights Presentations At The American Association for Study of Liver Diseasess Industry Colloquium For Novel Targets And Therapies In Liver Disease 3/20/2015 8:01:43 AM
Tobira Therapeutics Inc. Closes Financing To Support Development Of CVC In Non-Alcoholic Steatohepatitis 3/9/2015 7:06:08 AM
Regado Biosciences, Inc. (RGDO) And Tobira Therapeutics Inc. Merger Agreement Conference Call Set For 8:30 A.M. EST Today, Jan. 20 1/20/2015 7:59:14 AM
Tobira Therapeutics Inc. Doses First Subject In Phase 1 Clinical Trial Of Cenicriviroc And Pioglitazone 1/20/2015 6:48:12 AM
Troubled Regado Biosciences, Inc. (RGDO) Finds a Way Out With $60 Million Merger Deal Tobira Therapeutics Inc. 1/14/2015 6:14:33 AM
Tobira Therapeutics Inc. Highlights Data Presentations At The American Association for Study of Liver Diseases Annual Meeting Supporting Its Phase 2b Program Of Cenicriviroc For Nonalcoholic Steatohepatitis 11/10/2014 9:11:09 AM
Tobira Therapeutics Inc. Doses First Patient In CENTAUR, A Phase 2b Study Of Cenicriviroc In Patients With Non-Alcoholic Steatohepatitis 10/13/2014 7:39:29 AM
Tobira Therapeutics Inc.' Cenicriviroc Shows Improvement In Liver Fibrosis Scores In Phase 2b Study To Be Presented At AASLD 10/1/2014 8:53:13 AM
Bay Area Biotech Firm Tobira Therapeutics Inc. Tables $74 Million IPO 8/7/2014 3:15:50 PM
12345
//-->